Today: 18 June 2026
Browse Category

Earnings Reports 6 January 2026

Kroger maintained its 2026 outlook after first-quarter sales exceeded forecasts, but adjusted earnings missed estimates by a cent. Shares fell in premarket trading due to margin pressure from price investments, higher transport costs, and changes in fuel mix. CarMax reported fiscal Q1 revenue of $8.01 billion, beating forecasts, driven by higher used-car prices and strong wholesale demand, though retail used-vehicle gross profit per unit declined and the company continued price cuts to boost sales. La-Z-Boy shares rebounded nearly 17% in after-hours trading after adjusted earnings beat expectations, with revenue flat year-over-year; retail expansion supported results, but same-store orders and Joybird sales remained weak. Micron Technology shares dropped 3.6% after a record close as semiconductor stocks slipped, with investors locking in profits rather than reacting to specific company news. Netflix shares declined amid deal speculation involving Roku and Lionsgate, with the next earnings date set for July 16; the stock’s outlook depends on ads, pricing, and engagement. AT&T shares dipped 1.23% before a slight premarket uptick, underperforming the broader market as telecom stocks were influenced more by rate changes than company news; its Q2 earnings call is upcoming. Dave & Buster’s shares fell 4.72% after earnings missed on revenue, profit, and comps, raising questions about future sales and free-cash-flow targets. Nokia shares dropped 3.32% in Helsinki after a recent surge, with its ADR slightly up in New York; the company is set to report soon. Ford shares lagged the S&P 500, with the company seeking to continue importing China-built Lincoln Nautilus as new U.S. rules for connected-car software approach.
UnitedHealth stock jumps on TPG-Optum UK deal report as Jan. 27 earnings loom

UnitedHealth stock jumps on TPG-Optum UK deal report as Jan. 27 earnings loom

UnitedHealth Group shares rose 2.1% to $349.25 after reports TPG neared a deal to buy its Optum UK unit, valuing the business at up to £1.4 billion. The move boosted the Dow, with UnitedHealth and Amazon contributing 87 points to a 218-point gain. The company will report full-year 2025 results and 2026 guidance on Jan. 27. The Optum UK sale is not finalized and could still fall through.
6 January 2026
··
SoFi stock drops below $30 after $1.59 billion share sale as options traders brace for a 13.7% earnings swing

SoFi stock drops below $30 after $1.59 billion share sale as options traders brace for a 13.7% earnings swing

SoFi Technologies shares dropped 8.9% to $26.68 after a $1.59 billion public offering of 57.8 million shares at $27.50 each. Underwriters included Goldman Sachs, BofA, Citigroup, Deutsche Bank, and Mizuho. Options activity surged, with call volume over three times normal and implied post-earnings moves near 14%. Wall Street remains split on valuation, with price targets ranging from $24 to $28.
6 January 2026
··
JPMorgan stock slips after record run as investors eye Jan. 13 earnings

JPMorgan stock slips after record run as investors eye Jan. 13 earnings

JPMorgan shares slipped 0.3% to $333 Tuesday, pulling back after Monday’s record high. The bank’s new Special Advisory Services unit drew attention, while investors await fourth-quarter results due January 13. JPMorgan’s board declared a $1.50 dividend payable January 31 to holders as of January 6. Cost pressures remain a risk, with 2026 expenses projected at $105 billion.
6 January 2026
··
Tesla stock slides on Europe sales slump as BYD gains; traders eye Jan. 28 earnings

Tesla stock slides on Europe sales slump as BYD gains; traders eye Jan. 28 earnings

Tesla shares fell 3.2% to $437.13 Tuesday after German data showed December sales dropped 48% year-on-year. UK registrations slid 29% as Chinese rival BYD surged. Tesla lost its global EV sales lead to BYD after a second annual decline. Investors are watching for growth in AI and autonomous driving as EV demand slows.
6 January 2026
····
Spotify stock premarket: SPOT steadies near $600 as earnings, pricing loom

Spotify stock premarket: SPOT steadies near $600 as earnings, pricing loom

Spotify shares edged up 0.1% to $593.99 in Tuesday premarket trading after a 3.2% gain Monday. The company will report fourth-quarter results on Feb. 10, with investors watching for updates on U.S. subscription price hikes and profit targets. Spotify recently launched music videos for premium users in the U.S. and Canada. A new lawsuit alleges paid automated streams on platforms including Spotify, though the company is not a defendant.
6 January 2026
··
SoFi stock steadies near $29 after share-sale update; what to watch before Jan. 30 earnings

SoFi stock steadies near $29 after share-sale update; what to watch before Jan. 30 earnings

SoFi Technologies shares slipped 0.1% to $29.26 premarket after a filing showed banks exercised an over-allotment option, bringing the total stock offering to 57.75 million shares at $27.50 each for about $1.6 billion in gross proceeds. The move clarifies recent dilution ahead of SoFi’s Jan. 30 earnings report. Traders are watching Fed signals and U.S. data for rate direction.
6 January 2026
··
Microchip Technology stock jumps about 4% premarket after sales forecast boost

Microchip Technology stock jumps about 4% premarket after sales forecast boost

Microchip Technology shares rose 4.1% to $69.82 in premarket trading after the company raised its fiscal Q3 net sales outlook to about $1.19 billion, above its previous range. The stock closed Monday at $67.06, up 3.12%. CEO Steve Sanghi cited strong bookings and a higher starting backlog for the March quarter. JPMorgan raised its price target to $85 following the update.
6 January 2026
···
Delta Air Lines stock nudges higher in premarket after Goldman lifts target ahead of earnings

Delta Air Lines stock nudges higher in premarket after Goldman lifts target ahead of earnings

Delta Air Lines shares rose 0.3% to $72.03 in premarket trading Tuesday after Goldman Sachs raised its price target to $77 ahead of Delta’s January 13 earnings webcast. The stock closed up 4% Monday, outpacing airline peers. Delta added flights in the Caribbean after FAA airspace closures disrupted weekend travel. Oil prices fell Tuesday, easing jet fuel cost concerns.
6 January 2026
···
Telstra share price slips as rate-hike bets rise — what to watch before CPI and Feb earnings

Telstra share price slips as rate-hike bets rise — what to watch before CPI and Feb earnings

Telstra shares closed down 0.4% at A$4.82 on Tuesday, trading between A$4.79 and A$4.85. The move comes ahead of Australia’s November CPI report due Wednesday, with markets pricing a 39% chance of a February rate hike. Telstra’s half-year results are set for Feb. 19, with the stock turning ex-dividend Feb. 25. The ASX 200 finished down about 0.5%.
6 January 2026
··
GE Vernova stock edges higher after Vietnam gas-plant start; Jan. 28 earnings now in focus

GE Vernova stock edges higher after Vietnam gas-plant start; Jan. 28 earnings now in focus

GE Vernova shares closed up 0.2% at $680.86 Monday after announcing a 1.6-gigawatt LNG power plant in Vietnam began commercial operation. The Nhon Trach 3&4 facility, using GE’s 9HA turbines, is Vietnam’s first LNG-powered plant. The company set Jan. 28 for its fourth-quarter and full-year 2025 results. Trading volume was about 2.44 million shares.
6 January 2026
··
1 … 165 166 167 168 169 … 257

Stock Market Today

  • CervoMed Shares Surge on Dementia Drug Patent, Market Pulls Back on Equity Offering
    June 18, 2026, 4:08 PM EDT. CervoMed shares surged initially to $7.75 after U.S. patent allowance for neflamapimod in pure dementia with Lewy bodies (DLB) was announced, potentially protecting the drug through 2042. The company plans a $10 million registered direct equity offering at $4 per share, causing the stock to retrace gains and settle at $4.14. CervoMed aims to advance its oral DLB drug to late-stage trials, addressing an unmet need with no current approved treatments in the U.S. or EU. The equity raise, arranged by H.C. Wainwright, will support ongoing development and general corporate uses. The market reacted to the balance of intellectual property value against dilution risk. CervoMed's recent private placement extends its cash runway to Q2 2027, as it seeks a Phase 3 partner for neflamapimod.

Latest articles

CervoMed rises on patent news, pares gains after $10M equity sale

CervoMed rises on patent news, pares gains after $10M equity sale

18 June 2026
CervoMed shares soared to $7.75 intraday after announcing a U.S. patent allowance for neflamapimod in “pure” dementia with Lewy bodies patients, with protection expected into 2042, but gave back most gains after a $10 million share sale at $4 each; stock last up 8.7% at $4.14 on volume over 105 million shares.
Corning stock jumps 10% as AI data-center fiber trade draws fresh bids

Corning stock jumps 10% as AI data-center fiber trade draws fresh bids

18 June 2026
Corning shares soared 10.3% to $193.45 Thursday, outpacing the market as investors focused on its AI data-center optical-fiber deals with Amazon and Nvidia; core Q1 sales rose 18% to $4.35 billion, but risks remain from weak consumer demand and a high P/E ratio of 92, with the lowest analyst target at $180.
Amazon Shares Edge Higher, AI Chip Push Puts Spotlight on AWS Spend

Amazon Shares Edge Higher, AI Chip Push Puts Spotlight on AWS Spend

18 June 2026
Amazon shares jumped 2.4% after reports it’s in talks to sell its custom AI chips to other companies’ data centers, signaling a potential new revenue stream beyond AWS and raising investor hopes that Amazon’s heavy AI spending could soon deliver faster returns.
Go toTop